[Physiopathologic considerations on the action of glutamic acid in experimental mercury poisoning].
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001205:Ascorbic Acid / Q000627:therapeutic use; D002118:Calcium; D002614:Chelating Agents / Q000627:therapeutic use; D005971:Glutamates / Q000008:administration & dosage / Q000627:therapeutic use*; D005998:Glycine / Q000627:therapeutic use; D007668:Kidney / Q000201:enzymology / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008630:Mercury Poisoning / Q000188:drug therapy*; D009336:Necrosis / Q000139:chemically induced; D011188:Potassium; D011736:Pyridoxine / Q000627:therapeutic use; D051381:Rats; D012038:Regeneration; D012964:Sodium
D002614:Chelating Agents; D005971:Glutamates; D012964:Sodium; D000469:Alkaline Phosphatase; D011736:Pyridoxine; D001205:Ascorbic Acid; D011188:Potassium; D002118:Calcium; D005998:Glycine
Considérations physiopathologiques sur l'action de l'acide glutamique dans l'intoxication mercurielle expérimentale.